Severe nonimmune hydrops fetalis and congenital corneal opacification secondary to human parvovirus B19 infection: A case report

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 44, Issue 4, 1999, Pages 377-380

  Plachouras, Nicolaos ^a   Stefanidis, Konstantinos ^a,b   Andronikou, Styliani ^a   Lolis, Dimitrios ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b NONE   (Greece)

Author keywords

Corneal opacity; Human parvovirus B19; Hydrops fetalis

Indexed keywords

VIRUS ANTIBODY;

ADULT; ARTICLE; ASCITES; BLOOD TRANSFUSION; CASE REPORT; CHEMISTRY; CORNEA OPACITY; ECHOGRAPHY; FEMALE; FETUS BLOOD; FETUS DISEASE; FETUS HYDROPS; HUMAN; IMMUNOLOGY; PARVOVIRUS; PLEURA EFFUSION; VIROLOGY; VIRUS INFECTION;

ADULT; ANTIBODIES, VIRAL; ASCITES; BLOOD TRANSFUSION; CORNEAL OPACITY; FEMALE; FETAL BLOOD; FETAL DISEASES; HUMANS; HYDROPS FETALIS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PLEURAL EFFUSION; ULTRASONOGRAPHY, PRENATAL;

EID: 0040288542     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Rodis JF, Quinn DL, Gary GW Jr, et al: Management and outcomes of pregnancies complicated by human B19 parvovirus infection: A prospective study. Am J Obstet Gynecol 1990; 163:1168-1171
2. Kinney JS, Anderson LJ, Farrar J, et al: Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. J Infect Dis 1988;157:663-667
3. Van Elsacker Niele AMW, Weiland HT, Vermey-Keers C, et al: Fetal pathology in human parvovirus B19 infection. Br J Obstet Gynaecol 1989;96:768-775
4. Fairley CK, Smoleniec JS, Caul OE, et al: Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet 1995;346: 1335-1337
5. Kilham L, Margolis G: Problems of human concern arising from animal nodules of intrauterine and neonatal infections due to viruses. Prog Med Virol 1975;20:113-179
6. Weiland HI, Vermey-Keers C, Salimans MM, et al: Parvovirus B19 associated with fetal abnormality. Lancet 1987;1: 682-683
7. Mortimer PP, Luban NLC, Kelleher JF, et al: Transmission of serum parvovirus-like virus by clotting-factor concentrates. Lancet 1983;1:482-484
8. Evans JPM, Rossiter MA, Kumaran TO, et al: Human parvovirus aplasia: Case due to cross infection in a ward. Br Med J 1984;288:681
9. Carlson DE, Platt LD, Medearis AL, et al: Prognostic indicators of the resolution of non-immune hydrops fetalis and survival of the fetus. Am J Obstet Gynecol 1990;163:1785-1787
10. Gray ES, Davidson RJ, Anand A: Human parvovirus and fetal anaemia (lett). Lancet 1987;1:1144
11. Bron AJ, Tripathi RC: Corneal disorders. In Genetic and Metabolic Eye Diseases. Edited by MF Goldberg. Boston, Little, Brown, 1974, pp 281-323
12. Apple D, Rabb M: Clinicopathologic Correlation of Ocular Disease. Second edition. St Louis, CV Mosby, 1978, pp 95-106
13. Yanoff M, Fine B: Ocular Pathology. Second edition. Philadelphia, Harper & Row, 1982, pp 343-376
14. Waring GO III, Rodriques MM: Congenital and neonatal corneal abnormalities. In Duane's Foundations of Clinical Ophthalmology. Revised edition. Edited by W Tasman, EA Jaeger. Philadelphia, Lippincott-Raven, 1997, pp 1-38
15. Shapiro LJ: The mucopolysaccharidoses and mucolipidoses as model system for the investigations of genetic disorders. Birth Defects 1981;17:191-203
16. Vermey-Keers CHR: Primary congenital aphasia and the rubella syndrome. Teratology 1975;11:257-265
17. Hartwing NG, Vermey-Keers CHR, van Elsacker-Niele AMW, et al: Embryonic malformations in a case of intrauterine parvovirus B19 infection. Teratology 1989;9:295-303
18. Sebire NJ, Bianco D, Snijders RJ, et al: Increased nuchal translucency thickness at 10-14 weeks: Is screening for maternal-fetal infection necessary? Br J Obstet Gynaecol 1997;104:212-215